| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -729K | 100% | $17.45 | -$12.7M |
| Net | -8 | -729K | -100% | -$12.7M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher Anzalone | Chief Executive Officer, Director | $45.1M | -$8.62M | -16.1% | Apr 9, 2025 |
| Patrick O'Brien | COO and General Counsel | $10.4M | -$736K | -6.62% | Jan 4, 2025 |
| Kenneth Myszkowski | Chief Financial Officer | $8.97M | -$893K | -9.06% | Jan 4, 2025 |
| James Hamilton | Chief Medical Officer | $7.42M | -$1.92M | -20.6% | Oct 1, 2025 |
| Javier San | Chief Medical Officer | $7.42M | Jan 4, 2024 | ||
| James Hassard | Chief Commercial Officer | $3.95M | Jun 22, 2021 | ||
| Tracie Oliver | Chief Commercial Officer | $3.21M | Jul 2, 2024 | ||
| Michael Perry | Director | $3.02M | Dec 18, 2024 | ||
| Douglas B. Given | Director | $2.74M | -$122K | -4.25% | Dec 16, 2024 |
| Mauro Ferrari | Director | $1.78M | Dec 18, 2024 | ||
| Daniel Joseph Apel | Chief Financial Officer | $1.61M | Apr 15, 2025 | ||
| William D. Waddill | Director | $1.31M | -$165K | -11.1% | Dec 18, 2024 |
| Marianne De Backer | Director | $1.17M | Jan 10, 2023 | ||
| Hongbo Lu | Director | $1.08M | Dec 18, 2024 | ||
| Victoria Vakiener | Director | $872K | -$197K | -18.4% | Dec 18, 2024 |
| Douglas S. Ingram | Director | $771K | Feb 6, 2025 | ||
| Adeoye Y. Olukotun | Director | $751K | -$77.1K | -9.31% | Jan 23, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|